Blood Purification in Septic Children
NCT05595239 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120
Last updated 2026-02-17
Summary
In septic shock, dysregulated host responses to pathogens lead to cytokine storms that damage host tissues and organs, further contributing to the development of organ dysfunction and increased mortality. For sepsis, blood purification can remove inflammatory factors in sepsis by filtration or adsorption, so as to achieve the purpose of reducing inflammatory mediators in the body. However, there are few prospective randomized controlled studies in children. Therefore, this study intends to compare the efficacy and prognosis of different blood purifications on children with sepsis through randomized controlled studies, so as to provide a corresponding basis for the treatment of children with sepsis blood purification.
Conditions
- Sepsis
- Blood Purification
Interventions
- DEVICE
-
blood purification(CVVH)
After the sepsis patients were enrolled, they were treated with blood purification in CVVH mode, 24 hours per day, for 3 consecutive days
- DEVICE
-
blood purification(TPE+CVVH)
After the sepsis patients were enrolled, they were treated with blood purification in TPE mode 2 hours at first and then in CVVH mode 22 hours in the first two days, and then in CVVH mode 24 hours
- DEVICE
-
blood purification(HP+CVVH)
After the sepsis patients were enrolled, they were treated with blood purification in HP mode 2 hours at first and then in CVVH mode 22 hours in the first two days, and then in CVVH mode 24 hours
Sponsors & Collaborators
-
First Affiliated Hospital of Xinjiang Medical University
collaborator OTHER -
Shandong Provincial Hospital
collaborator OTHER_GOV -
Children's Hospital of Soochow University
collaborator OTHER -
Southern Medical University, China
collaborator OTHER -
Children's Hospital of Fudan University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- SEQUENTIAL
Eligibility
- Min Age
- 29 Days
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-07-01
- Primary Completion
- 2026-12-31
- Completion
- 2026-12-31
Countries
- China
Study Locations
More Related Trials
-
Cytokine Removal by CRRT in Pediatric Sepsis
NCT00537693 ·Status: COMPLETED ·Phase: NA
-
Early Identification and Effective Management of Pediatric Sepsis
NCT03996720 ·Status: COMPLETED
-
Impact of Continuous Venovenous Haemofiltration on Organ Failure During the Early Phase of Severe Sepsis
NCT00406198 ·Status: COMPLETED ·Phase: PHASE4
-
A Multi-Center Data System and Collaborative Network in China for Severe Infection and Sepsis Children
NCT04955210 ·Status: RECRUITING
-
Safety and Efficiency of Combined Extracorporeal Blood Purification in Neurosurgical ICU. Prospective RCT
NCT04152174 ·Status: UNKNOWN ·Phase: NA
-
Changes in Microvascular Perfusion During Blood Purification With Cytosorb® in Septic Shock
NCT03456180 ·Status: COMPLETED
-
Effects of Endotoxin Absorption and Cytokine Removal Hemofilter on Severe Septic Shock
NCT03974386 ·Status: COMPLETED ·Phase: NA
-
Strategy of Early Improvement of Tissue Oxygenation Decrease the Mortality of Severe Sepsis and Septic Shock
NCT01310790 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety Study of CA330 Hemoadsorption Device on IL-6 Removal in Septic Patients
NCT03847961 ·Status: UNKNOWN ·Phase: NA
-
Cytokine Adsorption in Severe, Refractory Septic Shock
NCT04910893 ·Status: COMPLETED ·Phase: NA
-
The Impact of Sepsis on Long-term Outcomes in Critical Ill Children With Sepsis
NCT06323226 ·Status: RECRUITING
-
Hemodynamic Impact of Cytosorb and CKRT in Children With Septic Shock
NCT05658588 ·Status: COMPLETED ·Phase: NA
-
A Blood Test to Diagnose Sepsis in Symptomatic Adults and Children
NCT05142813 ·Status: UNKNOWN
-
Effects of Renal Replacement Therapy With Hemoadsoption in Patients With Sepsis
NCT04533256 ·Status: COMPLETED
-
Blood Purification for the Treatment of Pathogen Associated Shock
NCT05011656 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The INFUSE Trial - Intervening With Platelet Transfusions in Sepsis
NCT03090919 ·Status: WITHDRAWN ·Phase: NA
-
Study on the Efficacy and Timing of ECMO Therapy in Children With Refractory Septic Shock
NCT03948048 ·Status: RECRUITING
-
Removal of mtDNA in Plasma by Continous Venovenous Hemofiltration in Sepsis
NCT04083482 ·Status: UNKNOWN ·Phase: NA
-
Effectiveness of Different Interventions for Implementing Surviving Sepsis Campaign (SSC) Guidelines on Compliance and Mortality: Systematic Review and Meta-analysis
NCT02069028 ·Status: UNKNOWN
-
Endotoxin Adsorber Hemoperfusion and Microcirculation
NCT01756755 ·Status: COMPLETED ·Phase: NA
-
Pro-inflammatory Cytokines Profile and Mortality Rate of Critically Ill Septic Patients Following Plasmapheresis
NCT01249222 ·Status: UNKNOWN ·Phase: NA
-
Novel Biomarkers for Early Renal Injury in Children With Sepsis
NCT06197828 ·Status: ACTIVE_NOT_RECRUITING
-
Pcrit and TPP for Risk Stratification in Patients with Sepsis
NCT06657196 ·Status: COMPLETED
-
Mecobalamin Combined With Ceftriaxone Sodium in the Treatment of Sepsis Liver Injury
NCT06220929 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Neutrophil Extracellular Traps and Neonatal (PV4991) & Pediatric Sepsis (PV5063)
NCT02567305 ·Status: UNKNOWN